162 related articles for article (PubMed ID: 11115261)
1. Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants.
Qian Y; Dekaris I; Yamagami S; Dana MR
Arch Ophthalmol; 2000 Dec; 118(12):1666-71. PubMed ID: 11115261
[TBL] [Abstract][Full Text] [Related]
2. Differential chemokine gene expression in corneal transplant rejection.
Yamagami S; Miyazaki D; Ono SJ; Dana MR
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2892-7. PubMed ID: 10549649
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival.
Hamrah P; Yamagami S; Liu Y; Zhang Q; Vora SS; Lu B; Gerard CJ; Dana MR
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1228-36. PubMed ID: 17325167
[TBL] [Abstract][Full Text] [Related]
4. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
Qian Y; Boisgerault F; Benichou G; Dana MR
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
[TBL] [Abstract][Full Text] [Related]
5. Role of tumor necrosis factor receptors TNFR-I (P55) and TNFR-II (P75) in corneal transplantation.
Yamada J; Streilein JW; Dana MR
Transplantation; 1999 Oct; 68(7):944-9. PubMed ID: 10532532
[TBL] [Abstract][Full Text] [Related]
6. Effect of locally administered anti-CD154 (CD40 ligand) monoclonal antibody on survival of allogeneic corneal transplants.
Qian Y; Dana MR
Cornea; 2002 Aug; 21(6):592-7. PubMed ID: 12131037
[TBL] [Abstract][Full Text] [Related]
7. Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).
Dana R
Trans Am Ophthalmol Soc; 2007; 105():330-43. PubMed ID: 18427620
[TBL] [Abstract][Full Text] [Related]
8. Effects of topical sphingosine-1-phosphate 1 receptor agonist on corneal allograft in mice.
Jia L; Liu Y; Wang L; Zhu J; Huang Y
Cornea; 2014 Apr; 33(4):398-404. PubMed ID: 24573171
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation.
Yamada J; Dana MR; Zhu SN; Alard P; Streilein JW
Arch Ophthalmol; 1998 Oct; 116(10):1351-7. PubMed ID: 9790635
[TBL] [Abstract][Full Text] [Related]
10. Allograft survival enhancement using doxycycline in alkali-burned mouse corneas.
Ling S; Li W; Liu L; Zhou H; Wang T; Ye H; Liang L; Yuan J
Acta Ophthalmol; 2013 Aug; 91(5):e369-78. PubMed ID: 23387987
[TBL] [Abstract][Full Text] [Related]
11. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
Niederkorn JY; Mayhew E; Mellon J; Hegde S
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
[TBL] [Abstract][Full Text] [Related]
12. Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts.
Dekaris IJ; Yamada JJ; Streilein WJ; Dana RM
Curr Eye Res; 1999 Nov; 19(5):456-9. PubMed ID: 10520223
[TBL] [Abstract][Full Text] [Related]
13. Cytokine expression during orthotopic corneal allograft rejection in mice.
Sano Y; Osawa H; Sotozono C; Kinoshita S
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1953-7. PubMed ID: 9727419
[TBL] [Abstract][Full Text] [Related]
14. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
15. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts.
Fairchild RL; VanBuskirk AM; Kondo T; Wakely ME; Orosz CG
Transplantation; 1997 Jun; 63(12):1807-12. PubMed ID: 9210509
[TBL] [Abstract][Full Text] [Related]
16. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
Solomon MF; Kuziel WA; Simeonovic CJ
Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of immunotherapeutic intervention by anti-CD154 (CD40L) antibody in high-risk corneal transplantation.
Qian Y; Hamrah P; Boisgerault F; Yamagami S; Vora S; Benichou G; Dana MR
J Interferon Cytokine Res; 2002 Dec; 22(12):1217-25. PubMed ID: 12581495
[TBL] [Abstract][Full Text] [Related]
18. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
19. Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment.
Torres PF; Slegers TP; Peek R; van Rooijen N; van der Gaag R; Kijlstra A; de Vos AF
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3194-201. PubMed ID: 10586942
[TBL] [Abstract][Full Text] [Related]
20. The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis.
Yu T; Forrester JV; Graham GJ; Kuffova L
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1875-1882. PubMed ID: 30054731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
